DNA X, Inc.
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsDNA X, Inc. (Nasdaq: SONM) is a San Diego-based cryptocurrency trading platform operator that sold its legacy phone and hotspot business in January 2026 and is now developing an AI-driven crypto trading service.
What they do
DNA X operates an internet cryptocurrency trading platform at dnax.us, serving individual traders who buy and sell cryptocurrencies with cash or cash equivalents, or swap one cryptocurrency for another. The company does not take custody of customer crypto assets; trades settle immediately and commissions are deducted from the trade. It also states it is developing products for buying and selling AI compute time. Previously named Sonim Technologies, Inc., the company completed the disposition of substantially all assets of its phone and hotspot business on January 23, 2026.
Revenue drivers
- DNA X cryptocurrency trading platform — Generates commission revenue from user trading and swapping activity on dnax.us; cost of revenue is primarily licensing fees fixed at 50% of commission revenue. The platform was closed to the public in March 2026 for redevelopment, so current revenue is minimal.
- Legacy phone and mobile hotspot business — Historically the main revenue source, reported as discontinued operations. Sold to NEXA Mobility on January 23, 2026 for a net sales price of $13,500, producing $6.3 million in net income in Q1 2026.
- AI compute time product — Under development only; no revenue has been reported from this activity.
Recent performance
For the three months ended March 31, 2026, the company reported no revenue from continuing operations because phone and hotspot revenue was classified as discontinued operations. General and administrative expenses from continuing operations were $3.6 million, including $1.5 million of one-time severance costs and $0.9 million in audit and tax professional services. The NEXA asset sale generated $6.3 million of net income in the quarter, net of taxes, transaction fees and severance. The company ended the quarter with $1.2 million in cash from continuing operations, and on May 20, 2026 agreed to raise an additional $1.8 million by issuing new debt. For the two months January and February 2026, the DNA X platform averaged $47 per month in commission revenue.
Strategy
Since closing the NEXA asset sale, management has focused on growing and developing the cryptocurrency trading platform, and closed the platform to the public in March 2026 to develop and test enhancements using third-party consultants and licensed software. The company expects to re-launch the platform in the fourth quarter of 2026 and expects commissions to return to early 2026 levels. Acting CEO Mike Mulica describes the transition as a reallocation of resources into decentralized AI and crypto trading. On May 26, 2026 the Put Option allowing DNA Holdings to reacquire DNA X LLC was terminated, giving the company full control; DNA X LLC is consolidated starting May 26, 2026. Financing has come from related-party DNA Holdings through convertible notes and convertible preferred stock.
Risks
- Platform shut down for redevelopment — The DNA X platform was closed to the public in March 2026, leaving the company with essentially no continuing revenue until a planned Q4 2026 re-launch and no guarantee the re-launch will produce anticipated commissions.
- Negative equity and thin cash — At June 30, 2026 total assets were $4.5 million, total liabilities $5.7 million, shareholder equity was negative $1.2 million and cash was $900,000, so operations depend on continued external or related-party financing.
- Cryptocurrency market and customer risk — Commission revenue depends on trading volume in volatile cryptocurrency markets, and the company is a small early-stage entrant competing with larger, established exchanges.
- Related-party dependence and ownership — Recent financing came from DNA Holdings through convertible notes and convertible preferred stock, and DNA Holdings had the right to reacquire DNA X LLC until the Put Option was terminated on May 26, 2026.
Outlook
Management says it expects to add features and products through the end of 2026 and to re-launch an enhanced DNA X platform to the public in the fourth quarter of 2026. It expects general and administrative expenses to be much lower in the next few quarters after downsizing the organization and completing the annual audit. The $1.8 million debt raised on May 20, 2026 is intended for working capital and to support and grow the AI and crypto trading business.